Pierrepont Therapeutics

Pittsburgh, United States

Pierrepont Therapeutics develops targeted treatments for primary mitochondrial diseases.

$500K raised

Apr 2024

Seed

Health Care Medical

Top Investors

Mito Fund

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about Pierrepont Therapeutics

How much funding has Pierrepont Therapeutics raised?

Pierrepont Therapeutics has raised $500K in total funding. The most recent round was Seed. The last funding was announced in April 2024.

Who are Pierrepont Therapeutics's investors?

Pierrepont Therapeutics's investors include Mito Fund.

Where is Pierrepont Therapeutics headquartered?

Pierrepont Therapeutics is headquartered in Pittsburgh, United States.

What does Pierrepont Therapeutics do?

Pierrepont Therapeutics develops targeted treatments for primary mitochondrial diseases.

What stage is Pierrepont Therapeutics at?

Pierrepont Therapeutics is at the Seed stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated April 4, 2024.

MLA

"Pierrepont Therapeutics — Funding & Investors." VCBacked, April 4, 2024, https://www.vcbacked.co/company/pierrepont-therapeutics. Accessed June 17, 2026.

APA

VCBacked. (2024). Pierrepont Therapeutics — Funding & Investors. Retrieved June 17, 2026, from https://www.vcbacked.co/company/pierrepont-therapeutics

Wikipedia (cite web)

{{cite web |title=Pierrepont Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/pierrepont-therapeutics |website=VCBacked |access-date=June 17, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated April 4, 2024.